Acute coronary syndrome - prasugrel with PCI (review TA182): Evaluation report
Please be advised that the format of evaluation reports shared on the NICE website has recently changed, for ease of user navigation between individual documents contained in the report.
It is a requirement of the new (PDF portfolio) format that Adobe Reader is used to view the document. Please follow the link at the bottom of this page to download Adobe Reader if required.
If you have any feedback on the new format please contact the Project Manager for this appraisal.
01. Overview prepared by NICE
02. Assesment Report prepared by LRiG
03. Comments on the Assessment Report - AstraZeneca
04. Comments on the Assessment Report - Lilly UK
05. Clinical expert personal perspective - Curzen
06. Patient expert personal perspective - Hartshorne-Evans
07. Clinical expert personal perspective - Kinnaird
08. Executive summary of technology manufacturers submission - Lilly UK
09. Consultee submission - British Cardiovascular Intervention Society
10. First addendum to the Assessment report - LriG
11. Second addendum to the Assessment Report - LriG
12. Third addendum to the Assesment Report - LriG
13. Erratum to the Assessment Report - LRiG
If you cannot open this document, you may have to save to your device and open.
Acute coronary syndrome - prasugrel with PCI (review TA182): Evaluation report
01 April 2014 (7.15 Mb 31 sec) |
This page was last updated: 28 March 2014